Oling, Nenette .
HRN: 02-16-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2025
CEFTRIAXONE 1G (VIAL)
12/23/2025
12/30/2025
IV
2G
OD
CRBSI
Waiting Final Action
12/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/23/2025
12/23/2025
IV
4.5g
STAT
CRBSI
Checking Initial Appropriateness
12/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/23/2025
12/30/2025
IV
2.25g
Q6H
CRBSI
Checking Initial Appropriateness